Hypertrophic cardiomyopathy patients presenting with a normal ECG exhibited a less severe phenotype and had significantly better cardiac survival, with 0 cardiac deaths at follow-up.
Cohort (n=2,485)
No
Does a normal ECG at presentation predict a less severe phenotype and better prognosis in patients with hypertrophic cardiomyopathy?
2,485 patients with hypertrophic cardiomyopathy (HCM) diagnosed by echocardiogram
Normal ECG at presentation
Abnormal ECG at presentation
Clinical phenotype and prognosis (cardiac survival)hard clinical
Patients with hypertrophic cardiomyopathy who present with a normal ECG represent a subset (approximately 6%) with a less severe clinical phenotype and excellent cardiovascular outcomes.
OBJECTIVES: This study sought to clarify the frequency, clinical phenotype, and prognosis of those patients with hypertrophic cardiomyopathy (HCM) who present with a normal electrocardiogram (ECG). BACKGROUND: Hypertrophic cardiomyopathy is the most common cause of sudden death in young people. Screening advocates have recommended a 12-lead ECG for the early detection of HCM in athletes, yet the clinical outcomes of those presenting with a normal ECG remains to be fully delineated. METHODS: Baseline characteristic and echocardiographic data were collected on all patients with HCM who initially presented to our institution with a diagnostic echocardiogram but a normal ECG. Follow-up was obtained and compared with the prognosis of HCM patients who presented with abnormal ECGs. RESULTS: We compared 135 HCM patients with a normal ECG with 2,350 HCM patients with an abnormal ECG. The latter group was more likely to have worse symptoms, have higher gradients, and a greater degree of septal wall thickness than the patients with a normal ECG. Severe obstructive symptoms requiring surgical myectomy and implantation of an implantable cardioverter-defibrillator were more common in patients with abnormal ECGs. Cardiac survival was significantly better in the group with a normal ECG at presentation-none of these patients had a cardiac death at follow-up. CONCLUSIONS: Almost 6% of patients presenting with demonstrable echocardiographic evidence of HCM had a normal ECG at the time of diagnosis. This subset of patients with normal ECG-HCM appears to exhibit a less severe phenotype with better cardiovascular outcomes.
Building similarity graph...
Analyzing shared references across papers
Loading...
Christopher J. McLeod
Electrophysiology
Michael J. Ackerman
Electrophysiology
Rick A. Nishimura
Structural Heart Disease
Journal of the American College of Cardiology
Mayo Clinic
Mayo Clinic in Arizona
Mayo Clinic in Florida
Building similarity graph...
Analyzing shared references across papers
Loading...
McLeod et al. (Wed,) conducted a cohort in Hypertrophic cardiomyopathy (n=2,485). Normal ECG vs. Abnormal ECG was evaluated on Cardiac survival. Hypertrophic cardiomyopathy patients presenting with a normal ECG exhibited a less severe phenotype and had significantly better cardiac survival, with 0 cardiac deaths at follow-up.
synapsesocial.com/papers/6a09dc6b4b6ade4638cab094 — DOI: https://doi.org/10.1016/j.jacc.2009.02.071